Cite

HARVARD Citation

    Bethel, M. et al. (2018). Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis. Lancet. 6 (2), pp. 105-113. [Online]. 
  
Back to record